daunorubicin has been researched along with dofequidar in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford, PJ; Germann, UA; Harding, MW; Mason, VS; Shlyakhter, D | 1 |
| Chen, Z; Kozaka, M; Liu, Z; Ohnishi, K; Ohno, R; Song, S; Takeshita, A; You, Y; Zou, P | 1 |
2 other study(ies) available for daunorubicin and dofequidar
| Article | Year |
|---|---|
Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
Topics: Acridines; Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; HL-60 Cells; Humans; Isoquinolines; Multidrug Resistance-Associated Proteins; Piperidines; Pyridines; Quinolines; Tetrahydroisoquinolines; Tritium; Verapamil; Vincristine | 1997 |
Multidrug resistance P-glycoprotein function of bone marrow hematopoietic cells and the reversal agent effect.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Bone Marrow Cells; Daunorubicin; Drug Resistance, Multiple; Hematopoietic Stem Cells; Humans; Quinolines | 1999 |